MedTrace Logo

Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants

NCT02024906 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-09-23

No results posted yet for this study

Summary

The purpose of this study is to help the researchers understand if using a soy supplement impacts cardiovascular disease risk factors in patients with subclinical hypothyroidism.

Conditions

Interventions

DIETARY_SUPPLEMENT

soy protein isolate (SPI)

DIETARY_SUPPLEMENT

milk protein isolate (MPI)

Sponsors & Collaborators

  • Soy Nutrition Institute

    collaborator UNKNOWN

  • Jill Hamilton-Reeves, PhD RD LD

    lead OTHER

Principal Investigators

  • Jill Hamilton-Reeves, PhD, RD, LD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02024906 on ClinicalTrials.gov